The Cheapest Way to Save a Patient’s Time May Be One We Will Not Pay For - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Home Leuprolide Appears Feasible, But Coverage Limits Access

  • By

  • Vishal R. Patel

  • Arjun Gupta

  • August 21, 2026

Share

Clinical Report: An Inexpensive Solution to Reduce Patient Time Commitment Might Be Underutilized

Overview

A pilot study demonstrated that patients with breast cancer can self-administer leuprolide injections at home, significantly reducing travel time and wait periods. However, insurance-related barriers prevented many interested patients from participating in home administration.

Background

Hormone-dependent malignancies often require long-term treatment with hormone-based agents, necessitating frequent clinic visits for injections. This can lead to significant time burdens for patients, termed 'time toxicity.' Exploring alternatives like home administration could alleviate these burdens.

Data Highlights

In the pilot study, 24 patients were trained to self-administer leuprolide injections at home. Of these, 23 successfully self-injected. Additionally, 75% of participants continued home administration after the study, particularly those residing over 50 miles from the clinic. However, 30 out of 54 interested patients faced insurance barriers that prevented their participation, and one patient reverted to clinic administration due to high out-of-pocket costs for home injections, which could reach up to $2000.

Key Findings

  • 23 of 24 patients successfully self-administered leuprolide injections at home after training.

  • Three-quarters of participants continued home injections after the study, especially those living more than 50 miles from the clinic.

  • Insurance barriers prevented 30 out of 54 interested patients from participating in the study.

  • One patient returned to clinic administration due to increased out-of-pocket costs for home injections.

  • Out-of-pocket expenses for home administration can reach up to $2000.

Clinical Implications

Healthcare providers should be aware of the potential for home administration of hormone therapies. Addressing insurance-related barriers is crucial.

Conclusion

The study demonstrates the feasibility of home self-injection for patients but highlights the need to address financial barriers.

Related Resources & Content

  1. Malling et al, Source, Year -- An Inexpensive Solution to Reduce Patient Time Commitment Might Be Underutilized

  2. optometric management — The Power of Efficient Patient Scheduling

  3. Ophthalmology Management — Increase Efficiency and Profitability in Your Clinic

  4. optometric management — Utilizing Staff for Patient Adherence

  5. Ophthalmology Management — Work Smarter, Not Harder

  6. The Power of Efficient Patient Scheduling

  7. Increase Efficiency and Profitability in Your Clinic

  8. Utilizing Staff for Patient Adherence

  9. EAU - EANM - ESTRO - Guidelines on Prostate Cancer

  10. Clinical Management of Ovarian Function Suppression in Premenopausal Women With Breast Cancer

  11. An Overview of Long-Acting GnRH Agonists in Premenopausal Breast Cancer Patients: Survivorship Challenges and Management - PMC

Original Source(s)

Related Content